Actively Recruiting
Testing Ketamine Assisted Mindfulness Therapy for Opioid Use Disorder in Adults
Led by University of Utah · Updated on 2023-07-05
60
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a Stage 1 randomized controlled trial to evaluate a new approach for treating opioid use disorder OUD. This study tests whether adding ketamine to an established mindfulness-based program called Mindfulness-Oriented Recovery Enhancement MORE can improve treatment outcomes. The trial compares the combined approach MORE plus ketamine-assisted psychotherapy to the standard MORE intervention among patients already receiving medications for OUD such as buprenorphine. The aim is to see if the combined treatment offers better results and to understand the psychological and biological factors involved. Participants are randomly assigned to one of two groups. One group receives 8 weeks of the standard mindfulness program MORE, while the other group receives the same mindfulness program plus two ketamine-assisted psychotherapy sessions, where ketamine is given intramuscularly at doses ranging from 0.5 to 1.5 mgkg. The study carefully monitors both treatments to assess their effects on opioid use disorder and related outcomes. During the study, participants are followed from the start through a 3-month period. Researchers will evaluate drug use as the primary outcome and also measure other factors including continued medication use, emotional distress, craving, mindfulness, and life meaning. Assessments include self-reports and psychobiological measures collected at baseline and follow-ups. Safety and adherence are monitored throughout the trial to ensure participant well-being and reliable results.
CONDITIONS
Brief Title
Ketamine Assisted Psychotherapy for Opioid Use Disorder
Research Team
R
Research Coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here